Category H

Posted 10 days ago
historical control subject
An individual treated in the past and used in a... (continued)
Posted 10 days ago
historic cohort study
A research study in which the medical records of groups... (continued)
Posted 10 days ago
HIV
The cause of acquired immunodeficiency syndrome (AIDS). Also called human... (continued)
Posted 10 days ago
HIV antibody
A substance produced by certain white blood cells in reaction... (continued)
Posted 10 days ago
hives
Itchy, raised red areas on the skin. Hives are caused... (continued)
Posted 10 days ago
Hivid
(Other name for: zalcitabine)
Posted 10 days ago
HIV positive
Infected with the human immunodeficiency virus (HIV), the cause of... (continued)
Posted 10 days ago
HLA
One of a group of proteins found on the surface... (continued)
Posted 10 days ago
HLA-A*0201-restricted TRP2-gp100-EphA2-HER2 multipeptide vaccine
A cancer vaccine containing four HLA-A*0201-restricted peptide epitopes with potential... (continued)
Posted 10 days ago
HLA-A*0201-restricted URLC10-VEGFR1-VEGFR2 multipeptide vaccine
A cancer vaccine containing three HLA-A*2402-restricted peptide epitopes with potential... (continued)
Posted 10 days ago
HLA-A*0201-restricted VEGFR1 peptide vaccine
A cancer vaccine containing an HLA-A*0201-restricted vascular endothelial growth factor... (continued)
Posted 10 days ago
HLA-A*0201-restricted VEGFR1-VEGFR2 multipeptide vaccine
A cancer vaccine containing two HLA-A*0201-restricted peptide epitopes with potential... (continued)
Posted 10 days ago
HLA-A1, A2, B35-restricted survivin peptides / Montanide ISA-51 vaccine
A peptide vaccine comprised of synthetic HLA-A1, -A2 and -B35... (continued)
Posted 10 days ago
HLA-A*2402-restricted KOC1-TTK-CO16-DEPDC1-MPHOSPH1 multipeptide vaccine
A cancer vaccine containing five HLA-A*2402-restricted peptide epitopes with potential... (continued)
Posted 10 days ago
HLA-A*2402-restricted URLC10-CDCA1-VEGFR1-VEGFR2 multipeptide vaccine
A cancer vaccine containing four HLA-A*2402-restricted peptide epitopes with potential... (continued)
Posted 10 days ago
HLA-A*2402-restricted URLC10-KOC1-VEGFR1-VEGFR2 multipeptide vaccine
A cancer vaccine containing four HLA-A*2402-restricted peptide epitopes with potential... (continued)
Posted 10 days ago
HLA-A*2402-restricted URLC10 peptides vaccine
A cancer vaccine containing HLA-A*2402-restricted epitope peptides URLC10 (up-regulated lung... (continued)
Posted 10 days ago
HLA-A*2402-restricted URLC10-TTK-KOC1 multipeptide vaccine
A cancer vaccine containing three HLA-A*2402-restricted peptide epitopes with potential... (continued)
Posted 10 days ago
HLA-A*2402-restricted URLC10-TTK-VEGFR1-VEGFR2 multipeptide vaccine
A cancer vacine containing four HLA-A*2402-restricted peptide epitopes with potential... (continued)
Posted 10 days ago
HLA-A*2402-restricted VEGFR1 peptide vaccine
A cancer vaccine containing the HLA-A*2402-restricted vascular endothelial growth factor... (continued)
Posted 10 days ago
HLA-A*2404-restricted RNF43-TOMM34-VEGFR1-VEGFR2 multipeptide vaccine
A cancer vaccine containing four HLA-A*2402-restricted peptide epitopes with potential... (continued)
Posted 10 days ago
HLA-A2, A3-restricted FGF-5 peptides / Montanide ISA-51 vaccine
A peptide vaccine comprised of synthetic HLA-A2- and HLA-A3-binding peptides,... (continued)
Posted 10 days ago
HLA-A2-restricted synthetic glioma antigen peptides vaccine
A synthetic peptide cancer vaccine consisting of HLA-A2-restricted peptides derived... (continued)
Posted 10 days ago
HLH
A rare disorder in which histiocytes and lymphocytes (types of... (continued)
Posted 10 days ago
hLL1
A substance being studied in the treatment of multiple myeloma... (continued)